(KSI) Kneat.com - Ratings and Ratios
Exchange: TO • Country: Ireland • Currency: CAD • Type: Common Stock • ISIN: CA4988241010
KSI: Software, Validation, Management, Document, Control, Services
Kneat.com, Inc., along with its subsidiaries, specializes in designing, developing, and delivering software solutions for data and document management within highly regulated industries. The company operates across key regions including North America, Europe, and the Asia-Pacific, serving sectors such as biotechnology, pharmaceuticals, and medical device manufacturing. Its flagship product, the Kneat Gx platform, is a configurable off-the-shelf solution tailored for validation lifecycle management and testing. This platform addresses a wide array of applications, encompassing document management, analytical instrument validation, method validation, commissioning and qualification, drawing management, utility and facility validation, cold chain validation, electronic logbook management, process validation, computer system validation, and cleaning validation. Additionally, the company offers professional services such as consulting, training, process mapping, project management, and other specialized services to complement its software offerings. Kneat.com, Inc. is headquartered in Limerick, Ireland, and can be visited online at https://kneat.com.
The companys focus is on streamlining validation processes, enhancing compliance, and improving operational efficiency for its clients. By providing a robust and scalable platform, Kneat.com, Inc. helps organizations in regulated industries maintain rigorous standards and reduce the complexity associated with validation and documentation management. Its solutions are particularly valuable in environments where precision, traceability, and regulatory adherence are paramount.
Additional Sources for KSI Stock
KSI Stock Overview
Market Cap in USD | 390m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
KSI Stock Ratings
Growth 5y | 80.0% |
Fundamental | -26.5% |
Dividend | 0.0% |
Rel. Strength Industry | 63.8 |
Analysts | - |
Fair Price Momentum | 6.86 CAD |
Fair Price DCF | - |
KSI Dividends
No Dividends PaidKSI Growth Ratios
Growth Correlation 3m | 54.1% |
Growth Correlation 12m | 96.7% |
Growth Correlation 5y | 66.4% |
CAGR 5y | 29.34% |
CAGR/Max DD 5y | 0.60 |
Sharpe Ratio 12m | -0.11 |
Alpha | 57.08 |
Beta | 0.82 |
Volatility | 61.74% |
Current Volume | 33.1k |
Average Volume 20d | 46.1k |
As of March 16, 2025, the stock is trading at CAD 6.08 with a total of 33,055 shares traded.
Over the past week, the price has changed by -6.03%, over one month by -10.85%, over three months by +3.05% and over the past year by +65.22%.
Probably not. Based on ValueRay Fundamental Analyses, Kneat.com (TO:KSI) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -26.47 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KSI as of March 2025 is 6.86. This means that KSI is currently undervalued and has a potential upside of +12.83% (Margin of Safety).
Kneat.com has no consensus analysts rating.
According to ValueRays Forecast Model, KSI Kneat.com will be worth about 7.7 in March 2026. The stock is currently trading at 6.08. This means that the stock has a potential upside of +27.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 8.4 | 37.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 7.7 | 27.1% |